Tau as a serum biomarker of delirium after major cardiac surgery: a single centre case-control study

Br J Anaesth. 2022 Jul;129(1):e13-e16. doi: 10.1016/j.bja.2022.04.002. Epub 2022 Apr 22.

Authors

Tina B McKay¹, Jason Qu², Feng Liang², Ariel Mueller², Jeanine Wiener-Kronish², Zhongcong Xie², Oluwaseun Akeju²

Affiliations

¹ Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: tmckay@mgh.harvard.edu.
² Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

No abstract available

Keywords: Alzheimer's disease; cardiopulmonary bypass; cognitive dysfunction; delirium; dementia; phospho-tau; post-surgical complications; tau.

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Biomarkers
Cardiac Surgical Procedures* / adverse effects
Case-Control Studies
Delirium* / diagnosis
Delirium* / etiology
Humans
tau Proteins

Substances

Biomarkers
tau Proteins

Grants and funding

R01 AG053582/AG/NIA NIH HHS/United States